ARCHIVES

NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level

This article is from The Cancer Letter archive.

Vol. 40 No. 10 | March 7, 2014

Download PDF Visit The Full Archive

Related Articles

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

Obituary: NCI’s Elaine Ron, Expert in Radiation Heath Effects

December 3, 2010

Outside NIH, Applied Research Underfunded; Strong Federal Role Needed, Chabner Says

May 12, 1995

In Brief: Cancer Research Institute to Support AIDS Grants, With Maximum $70,000 Each; Deadline Is Oct. 1

July 15, 1983

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

June 9, 2006